Skip to main content

Table 4 Factors associated with non-adherence to antidiabetic medication among patients with type 2 diabetes in Limbe and Bamenda Regional Hospitals, Cameroon, 2016

From: Adherence to antidiabetic medication and factors associated with non-adherence among patients with type-2 diabetes mellitus in two regional hospitals in Cameroon

Variable

OR (95% CI)

Adjusted OR (95% CI)

p-value

Age (in years)

 ≤ 60

  

0.02*

 > 60

0.44 (0.25–0.78)

0.48 (0.25–0.94)

Educational level

 Never gone to school

  Primary

2.74 (1.24–6.08)

1.71 (0.71–4.10)

0.52*

  Secondary

3.57 (1.40–9.08)

1.58 (0.54–4.62)

  High school /University

3.08 (1.17–8.07)

1.60 (0.49–5.20)

Gender

 Female

  

0.81*

 Male

1.39 (0.75–2.60)

1.07 (0.05–2.28)

Body-Mass Index, BMI (kg/m2)

0.99 (0.97–1.01)

 

0.55

Co-morbidity

 Hypertension

  

0.35

  No

  

  Yes

0.76 (0.42–1.36)

 

 Chronic renal disease

  No

  

0.35

  Yes

2.13 (0.40–11.25)

 

 Stroke

  

0.51

  No

  

  Yes

0.54 (0.09–3.34)

 

Duration of diabetes (in years)

 < 5 years

  

0.22

 6–10 years

2.28 (1.08–4.84)

 

 11–20 years

1.69 (0.82–3.50)

 

 > 20 years

0.53 (0.13–2.26)

 

Alcohol consumption

 No

  

0.04*

 Yes

2.05 (1.13–3.72)

2.13 (1.10–4.14)

Tobacco use

 No

  

0.67

 Yes

1.67 (0.15–18.76)

 

Number of diabetic complications

 None

  

0.54

  1

1.34 (0.72–2.49)

 

  2 or more

1.46 (0.64–3.35)

 

Current antidiabetic medications

 Single OHA

  Two OHA

1.25 (0.63–2.50)

1.16 (0.56–2.42)

0.04*

  Insulin alone

3.15 (1.19–8.34)

2.85 (1.01–8.08)

  Insulin and OHA

2.22 (0.95–5.20)

0.78 (0.76–4.71)

  1. *p-value on multivariable analysis, OHA oral hypoglycaemic agent, BMI body mass index, ref. reference, OR odds ratio, CI confidence interval